Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Horse Chestnut Seed Extract + Micronized Purified Flavonoid Fraction for Chronic Venous Disease
ChiCTR2600122968Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Apr 2026
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic venous disease (CVD) comparing MPFF + HCSE combination with MPFF monotherapy (2 arms). Primary endpoints: Global venous symptom score and Time to symptom relief. Started Apr 2026; status: recruiting.
02
Drugs
micronized purified flavonoid fractionHorse chestnut seed extract
03
Conditions
chronic venous disease (CVD)
Beyond the preview
Go deeper on ChiCTR2600122968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122968.